- Home
- AXP vs NVS Comparison
AXP vs NVS Comparison
Compare AXP & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXP | NVS |
|---|---|---|
| Founded | 1850 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.1B | 254.8B |
| IPO Year | N/A | 1991 |
Fundamental Metrics
Financial Performance| Metric | AXP | NVS |
|---|---|---|
| Price | $380.20 | $132.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 4 |
| Target Price | ★ $327.57 | $118.00 |
| AVG Volume (30 Days) | ★ 2.5M | 1.8M |
| Earning Date | 01-23-2026 | 01-30-2026 |
| Dividend Yield | 0.86% | ★ 1.96% |
| EPS Growth | ★ 9.59 | N/A |
| EPS | ★ 14.88 | 7.30 |
| Revenue | ★ $65,294,000,000.00 | $56,372,000,000.00 |
| Revenue This Year | $19.83 | $9.33 |
| Revenue Next Year | $8.85 | $2.75 |
| P/E Ratio | $25.72 | ★ $18.16 |
| Revenue Growth | 10.22 | ★ 12.88 |
| 52 Week Low | $220.43 | $96.06 |
| 52 Week High | $387.49 | $134.24 |
Technical Indicators
Market Signals| Indicator | AXP | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 65.30 | 57.20 |
| Support Level | $360.70 | $130.46 |
| Resistance Level | $374.88 | $133.84 |
| Average True Range (ATR) | 7.43 | 1.68 |
| MACD | 1.82 | 0.13 |
| Stochastic Oscillator | 85.26 | 75.78 |
Price Performance
Historical ComparisonAbout AXP American Express Company
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. It operates in four segments: US consumer services, US commercial services, international card services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.